Alejandro Dorenbaum
Academic Appointments
- Clinical Associate Professor, Pediatrics - Immunology and Allergy
Key Documents
Contact Information
-
Clinical Offices
Pediatric Allergy & Immunology 730 Welch Road Allergy Clinic Palo Alto, CA 94305 Tel Work (650) 723-0290Practices at Lucile Packard Children's Hospital
- Academic Offices
Personal Information Tel (650) 723-5227Alternate Contact Lorna Groundwater Administrative Associate Email Tel Work 650 498-6073
Professional Overview
Clinical Focus
- Allergy and Immunology
- Pediatric Allergy/Immun
Administrative Appointments
- Clinical Associate Professor, Stanford University School of Medicine (2004 - present)
- Clinical Assistant Professor, Stanford University School of Medicine (2000 - 2004)
Honors and Awards
- Excellence in Teaching Award, Department of Pediatrics, UCSF (1997)
- Excellence in Teaching Award, Department of Pediatrics, UCSF (1995)
- Schering Travel Grant Award, 48th Annual Meeting of the AAAAI (1992)
- Schering Travel Grant Award, 47th Annual Meeting of the AAAAI (1991)
Professional Education
| Board Certification: | Allergy and Immunology, American Board of Allergy and Immunology (1997) |
| Board Certification: | American Board of Pediatrics, Pediatrics (1990) |
| Fellowship: | Baylor College of Medicine TX (1992) |
| Internship: | Univ Of Texas Health Science Ctr at Houston TX (1988) |
| Medical Education: | Universidad Autonoma Metropolitana, Mexico (1986) |
Graduate & Fellowship Program Affiliations
Community and International Work
- New Anti-HIV Medications: A Look at Nevirapine, International
- National Youth Leadership Forum on Medicine, Bay Area
- Bring Your Daughter to Work Program, UCSF
- Pediatric HIV Infection, from Diagnosis to Chronic Care, San Francisco
- Introduction to the Human Immune System, San Francisco
- HIV Weekly Update, Bay Area
Scientific Focus
Publications
- Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults. Clin Ther. 2010; (2): 338-46
- Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study. J Pediatr. 2009; (5): 700-7
- Pharmacokinetics of sapropterin in patients with phenylketonuria. Clin Pharmacokinet. 2008; (12): 817-25
- Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria. Am J Med Genet A. 2008; (22): 2851-9
- Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol Genet Metab. 2007 Sep-Oct; (1-2): 63-70
- Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study. Lancet. 2007; (9586): 504-10
